beyfortus - nirsevimab injection
(Nirsevimab)Sanofi Pasteur Inc.
Usage: BEYFORTUS is indicated for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season, as well as in children up to 24 months who are vulnerable to severe RSV disease through their second RSV season.